On Feb. 15, the U.S. Food and Drug Administration (FDA) will decide whether to authorize Pfizer’s COVID shot for infants and toddlers. A look at how other countries have responded so far to U.S. regulators’ decisions on COVID vaccines suggests many other countries will do whatever the FDA recommends.